DePrince Race & Zollo Inc (DRZ)’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-180,975
| Closed | -$11M | – | 208 |
|
|
2022
Q3 | $11M | Sell |
180,975
-187,782
| -51% | -$12M | 0.28% | 123 |
|
|
2022
Q2 | $23.2M | Sell |
368,757
-979
| -0.3% | -$64.8K | 0.54% | 92 |
|
|
2022
Q1 | $26M | Sell |
369,736
-905
| -0.2% | -$61.2K | 0.51% | 97 |
|
|
2021
Q4 | $23.2M | Buy |
370,641
+19,268
| +5% | +$1.21M | 0.59% | 85 |
|
|
2021
Q3 | $21.7M | Sell |
351,373
-6,007
| -2% | -$362K | 0.58% | 93 |
|
|
2021
Q2 | $21.4M | Sell |
357,380
-12,024
| -3% | -$762K | 0.54% | 96 |
|
|
2021
Q1 | $22.5M | Sell |
369,404
-49,965
| -12% | -$2.76M | 0.6% | 76 |
|
|
2020
Q4 | $19.7M | Buy |
419,369
+1,014
| +0.2% | +$43.9K | 0.62% | 66 |
|
|
2020
Q3 | $15.6M | Buy |
418,355
+1,970
| +0.5% | +$74.8K | 0.58% | 72 |
|
|
2020
Q2 | $15.2M | Buy |
416,385
+34,960
| +9% | +$1.22M | 0.59% | 72 |
|
|
2020
Q1 | $11.7M | Buy |
381,425
+1,520
| +0.4% | +$67.4K | 0.53% | 88 |
|
|
2019
Q4 | $19.4M | Sell |
379,905
-50,824
| -12% | -$2.45M | 0.59% | 77 |
|
|
2019
Q3 | $20.3M | Buy |
430,729
+13,395
| +3% | +$639K | 0.59% | 78 |
|
|
2019
Q2 | $20.7M | Sell |
417,334
-114,870
| -22% | -$5.4M | 0.58% | 77 |
|
|
2019
Q1 | $22.7M | Buy |
532,204
+25,624
| +5% | +$1.13M | 0.62% | 59 |
|
|
2018
Q4 | $20.8M | Buy |
506,580
+1,590
| +0.3% | +$68.2K | 0.6% | 66 |
|
|
2018
Q3 | $23.6M | Buy |
504,990
+17,679
| +4% | +$808K | 0.53% | 80 |
|
|
2018
Q2 | $21.2M | Sell |
487,311
-11,121
| -2% | -$518K | 0.49% | 86 |
|
|
2018
Q1 | $22.9M | Buy |
498,432
+74,178
| +17% | +$3.6M | 0.54% | 85 |
|
|
2017
Q4 | $21.4M | Sell |
424,254
-18,126
| -4% | -$955K | 0.48% | 96 |
|
|
2017
Q3 | $23M | Sell |
442,380
-168,217
| -28% | -$8.19M | 0.52% | 89 |
|
|
2017
Q2 | $29.9M | Buy |
610,597
+35,370
| +6% | +$1.64M | 0.61% | 66 |
|
|
2017
Q1 | $27.1M | Sell |
575,227
-3,584
| -0.6% | -$171K | 0.56% | 78 |
|
|
2016
Q4 | $27.8M | Sell |
578,811
-102,575
| -15% | -$4.7M | 0.54% | 97 |
|
|
2016
Q3 | $27M | Sell |
681,386
-128,837
| -16% | -$4.84M | 0.57% | 92 |
|
|
2016
Q2 | $28.8M | Buy |
810,223
+51,059
| +7% | +$1.99M | 0.58% | 87 |
|
|
2016
Q1 | $29.7M | Sell |
759,164
-91,963
| -11% | -$3.44M | 0.6% | 85 |
|
|
2015
Q4 | $36.6M | Buy |
851,127
+32,852
| +4% | +$1.44M | 0.68% | 65 |
|
|
2015
Q3 | $34.4M | Sell |
818,275
-69,934
| -8% | -$3.27M | 0.61% | 70 |
|
|
2015
Q2 | $44.3M | Sell |
888,209
-127,381
| -13% | -$6.03M | 0.65% | 61 |
|
|
2015
Q1 | $45.8M | Buy |
1,015,590
+104,486
| +11% | +$4.7M | 0.64% | 64 |
|
|
2014
Q4 | $43.9M | Sell |
911,104
-33,077
| -4% | -$1.57M | 0.6% | 79 |
|
|
2014
Q3 | $45.2M | Sell |
944,181
-45,607
| -5% | -$2.22M | 0.61% | 68 |
|
|
2014
Q2 | $49M | Sell |
989,788
-17,615
| -2% | -$824K | 0.58% | 70 |
|
|
2014
Q1 | $47.4M | Sell |
1,007,403
-47,910
| -5% | -$2.2M | 0.57% | 73 |
|
|
2013
Q4 | $50.7M | Sell |
1,055,313
-19,971
| -2% | -$895K | 0.64% | 52 |
|
|
2013
Q3 | $45M | Sell |
1,075,284
-102,888
| -9% | -$4.43M | 0.61% | 60 |
|
|
2013
Q2 | $48.1M | Buy |
+1,178,172
| New | +$43.3M | 0.66% | 51 |
|
Other funds holding MET
AWA
DePrince Race & Zollo Inc (DRZ)'s MET Position: Q4 2022 in Review
DePrince Race & Zollo Inc (DRZ) sold out of MetLife (MET) in Q4 2022, closing a stake of 180,975 shares — an estimated $11M sold.
DePrince Race & Zollo Inc (DRZ) first reported a position in MET in Q2 2013 and held it in 38 quarters. The position peaked at $50.7M in Q4 2013. 1,316 funds tracked by Wall St. Rank hold MET as of Q4 2022.
- DePrince Race & Zollo Inc (DRZ) reported no remaining MetLife position as of Q4 2022 after selling out during the quarter.
- DePrince Race & Zollo Inc (DRZ) sold 180,975 MetLife shares in Q4 2022, an estimated $11M.
- DePrince Race & Zollo Inc (DRZ) first reported a position in MetLife in Q2 2013 and held it in 38 quarters.
- DePrince Race & Zollo Inc (DRZ)'s MetLife position peaked at $50.7M in Q4 2013.
- 1,316 funds tracked by Wall St. Rank held MetLife as of Q4 2022.
Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q4 2022, filed 14 Feb 2023.